Paediatric patients with the syndrome of an inappropriate antidiuretic hormone secretion (SIADH), as a manifestation of inflammatory demyelinating disorders of the central nervous system, have been rarely described until now, in only a few cases of neuromyelitis optica spectrum disorders (NMOSDs). We present a case of relapsing SIADH associated with NMOSD, in an anti-aquaporin-4 antibody positive 14-year-old girl, who is, to our best knowledge, the first reported paediatric patient with relapsing SIADH and NMOSD. Additionally, our case further supports the notion that paediatric encephalomyelitis associated with SIADH should suggest the diagnosis of NMOSD.
SchwartzWBBennettWCurelopS. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med1957; 23: 529–542.
2.
LotzeTENorthropJLHuttonGJ. Spectrum of pediatric neuromyelitis optica. Pediatrics2008; 122: e1039–1047.
3.
IorioRLucchinettiCFLennonVA. Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica. Neurology2011; 77: 1644–1646.
4.
McKeonALennonVALotzeT. CNS aquaporin-4 autoimmunity in children. Neurology2008; 71: 93–100.
5.
KhuranaM.Disorders of salt and water balance. In: KiesslingSGSomersMJG (eds) Pediatric nephrology in the ICU. Berlin; Heidelberg: Springer-Verlag, 2009, pp.1–18.
6.
NakajimaHFujikiYItoT. Anti-aquaporin-4 antibody-positive neuromyelitis optica presenting with syndrome of inappropriate antidiuretic hormone secretion as an initial manifestation. Case Rep Neurol2011; 3: 263–267.
7.
BreningstallG.An 11-year-old girl with syndrome of inappropriate antidiuretic hormone secretion. Semin Pediatr Neurol1999; 6: 202–208.
8.
WingerchukDMLennonVAPittockSJ. Revised diagnostic criteria for neuromyelitis optica. Neurology2006; 66: 1485–1489.
9.
TrebstCJariusSBertheleA. Neuromyelitis Optica Study Group (NEMOS). Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol2014; 261: 1–16.
10.
GreenbergBMGravesDRemingtonG. Rituximab dosing and monitoring strategies in neuromyelitis optica patients: Creating strategies for therapeutic success. Mult Scler2012; 18: 1022–1026.
